These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2093019)

  • 21. Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole.
    Pace F; Annese V; Prada A; Zambelli A; Casalini S; Nardini P; Bianchi Porro G;
    Dig Liver Dis; 2005 Oct; 37(10):741-50. PubMed ID: 16024305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
    Lundell L; Backman L; Ekström P; Enander LK; Falkmer S; Fausa O; Grimelius L; Havu N; Lind T; Lönroth H
    Scand J Gastroenterol; 1991 Mar; 26(3):248-56. PubMed ID: 1853146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.
    Bate CM; Booth SN; Crowe JP; Mountford RA; Keeling PW; Hepworth-Jones B; Taylor MD; Richardson PD
    Gut; 1995 Apr; 36(4):492-8. PubMed ID: 7737552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.
    Sandmark S; Carlsson R; Fausa O; Lundell L
    Scand J Gastroenterol; 1988 Jun; 23(5):625-32. PubMed ID: 3041558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
    James OF; Parry-Billings KS
    Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis].
    Bergmann JF; Hamelin B; Barbier JP
    Gastroenterol Clin Biol; 1995 May; 19(5):482-6. PubMed ID: 7589999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
    Cucchiara S; Minella R; Iervolino C; Franco MT; Campanozzi A; Franceschi M; D'Armiento F; Auricchio S
    Arch Dis Child; 1993 Dec; 69(6):655-9. PubMed ID: 8285777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?
    Bate CM; Booth SN; Crowe JP; Hepworth-Jones B; Taylor MD; Richardson PD
    Aliment Pharmacol Ther; 1993 Oct; 7(5):501-7. PubMed ID: 8280818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Healing and relapse of severe peptic esophagitis after treatment with omeprazole.
    Hetzel DJ; Dent J; Reed WD; Narielvala FM; Mackinnon M; McCarthy JH; Mitchell B; Beveridge BR; Laurence BH; Gibson GG
    Gastroenterology; 1988 Oct; 95(4):903-12. PubMed ID: 3044912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD; Tassios PS; Raptis SA
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
    Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
    Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.
    Carlsson R; Galmiche JP; Dent J; Lundell L; Frison L
    Aliment Pharmacol Ther; 1997 Jun; 11(3):473-82. PubMed ID: 9218069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omeprazole in the short-term treatment of reflux oesophagitis.
    Jansen JB; Lamers CB
    Digestion; 1989; 44 Suppl 1():40-6. PubMed ID: 2691310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE; Fraga P; Mack M; Sabesin SM; Bochenek W;
    Aliment Pharmacol Ther; 2004 Sep; 20(5):567-75. PubMed ID: 15339328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
    Klinkenberg-Knol EC; Festen HP; Meuwissen SG
    Aliment Pharmacol Ther; 1988 Jun; 2(3):221-7. PubMed ID: 2979246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.
    Klinkenberg-Knol EC; Meuwissen SG
    Digestion; 1992; 51 Suppl 1():44-8. PubMed ID: 1356868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omeprazole in the treatment of patients with severe reflux oesophagitis not responding to H2-receptor antagonists and ineligible for surgery.
    Fiasse R; Druez P; Coppens JP; Delhaze M; Fabre C; Pauwels S; Dive C
    Acta Gastroenterol Belg; 1990; 53(5-6):573-84. PubMed ID: 2130587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Erosive oesophagitis: outcome of repeated long term maintenance treatment with low dose omeprazole 10 mg or placebo.
    Bardhan KD; Cherian P; Vaishnavi A; Jones RB; Thompson M; Morris P; Brooks A; D'Silva J; Gillon KR; Wason C; Patterson J; Polak J; Bishop A
    Gut; 1998 Oct; 43(4):458-64. PubMed ID: 9824569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroesophageal reflux disease in intellectually disabled individuals: leads for diagnosis and the effect of omeprazole therapy.
    Bohmer CJ; Niezen-de Boer MC; Klinkenberg-Knol EC; Tuynman HA; Voskuil JH; Devillé WL; Meuwissen SG
    Am J Gastroenterol; 1997 Sep; 92(9):1475-9. PubMed ID: 9317066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.